1. Emerging Technologies for Molecular Diagnosis of Sepsis
- Author
-
Shelley M. Lawrence, Mridu Sinha, Hannah Mack, Todd P. Coleman, Stephanie I. Fraley, and Julietta Jupe
- Subjects
0301 basic medicine ,Epidemiology ,diagnostic ,Review ,Medical and Health Sciences ,biomedical engineering ,Blood culture ,DNA sequencing ,screening and diagnosis ,medicine.diagnostic_test ,Electronic medical record ,Hematology ,Detection ,Infectious Diseases ,Molecular Diagnostic Techniques ,Infection ,Biotechnology ,4.2 Evaluation of markers and technologies ,Microbiology (medical) ,medicine.medical_specialty ,Polymicrobial infection ,Emerging technologies ,infectious disease ,030106 microbiology ,Microbiology ,microbiology techniques ,Vaccine Related ,Sepsis ,03 medical and health sciences ,Antibiotic resistance ,Clinical Research ,Biodefense ,medicine ,Humans ,Intensive care medicine ,Bacteriological Techniques ,Agricultural and Veterinary Sciences ,General Immunology and Microbiology ,business.industry ,Prevention ,Inflammatory and immune system ,Public Health, Environmental and Occupational Health ,Small sample ,medicine.disease ,4.1 Discovery and preclinical testing of markers and technologies ,Emerging Infectious Diseases ,Infectious disease (medical specialty) ,Antimicrobial Resistance ,business - Abstract
SUMMARY Rapid and accurate profiling of infection-causing pathogens remains a significant challenge in modern health care. Despite advances in molecular diagnostic techniques, blood culture analysis remains the gold standard for diagnosing sepsis. However, this method is too slow and cumbersome to significantly influence the initial management of patients. The swift initiation of precise and targeted antibiotic therapies depends on the ability of a sepsis diagnostic test to capture clinically relevant organisms along with antimicrobial resistance within 1 to 3 h. The administration of appropriate, narrow-spectrum antibiotics demands that such a test be extremely sensitive with a high negative predictive value. In addition, it should utilize small sample volumes and detect polymicrobial infections and contaminants. All of this must be accomplished with a platform that is easily integrated into the clinical workflow. In this review, we outline the limitations of routine blood culture testing and discuss how emerging sepsis technologies are converging on the characteristics of the ideal sepsis diagnostic test. We include seven molecular technologies that have been validated on clinical blood specimens or mock samples using human blood. In addition, we discuss advances in machine learning technologies that use electronic medical record data to provide contextual evaluation support for clinical decision-making.
- Published
- 2018
- Full Text
- View/download PDF